Song, A., Lee, A., Garofolo, F., Kaur, S., Duggan, J., Evans, C., Palandra, J., Donato, L. D., Xu, K., Bauer, R., Bustard, M., Chen, L., Cocea, L., Croft, S., Galliccia, F., Haidar, S., Hughes, N., Ishii-Watabe, A., Islam, R., Jones, B., Kadavil, J., Krantz, C., Lima Santos, G. M., Olah, T., Pedras-Vasconcelos, J., Staelens, L., Saito, Y., Savoie, N., Scheibner, K., Spitz, S., Tampal, N., Thomas, E., Vinter, S., Wakelin-Smith, J., Welink, J., Zeng, J., & Zhou, S. (2016). 2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV): (Part 2 – Hybrid LBA/LCMS and input from regulatory agencies). Bioanalysis, 8, 2457–2474. http://access.bl.uk/ark:/81055/vdc_100137419307.0x000006